WO2005097208A3 - Tissue oxygenation measurements - Google Patents
Tissue oxygenation measurements Download PDFInfo
- Publication number
- WO2005097208A3 WO2005097208A3 PCT/US2005/010112 US2005010112W WO2005097208A3 WO 2005097208 A3 WO2005097208 A3 WO 2005097208A3 US 2005010112 W US2005010112 W US 2005010112W WO 2005097208 A3 WO2005097208 A3 WO 2005097208A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tissue oxygenation
- contrast agent
- mri
- methods
- peg
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/14—Peptides, e.g. proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/12—Macromolecular compounds
- A61K49/126—Linear polymers, e.g. dextran, inulin, PEG
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55693204P | 2004-03-26 | 2004-03-26 | |
US60/556,932 | 2004-03-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005097208A2 WO2005097208A2 (en) | 2005-10-20 |
WO2005097208A3 true WO2005097208A3 (en) | 2006-01-26 |
Family
ID=35125629
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/010112 WO2005097208A2 (en) | 2004-03-26 | 2005-03-25 | Tissue oxygenation measurements |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2005097208A2 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9339559B2 (en) | 2005-09-09 | 2016-05-17 | Georgia State University Research Foundation, Inc. | Targeted contrast agents and methods for targeting contrast agents |
WO2009146099A2 (en) | 2008-04-02 | 2009-12-03 | Georgia State University Research Foundation, Inc. | Contrast agents, methods for preparing contrast agents, and methods of imaging |
GB0812191D0 (en) * | 2008-07-03 | 2008-08-13 | Greater Glasgow Health Board | Modified cells and methods of monitoring their viability |
AU2009271530B2 (en) | 2008-07-18 | 2016-01-07 | Oxygen Biotherapeutics, Inc. | Method of treating traumatic brain injury |
US10751464B2 (en) | 2009-08-25 | 2020-08-25 | Nanoshell Company, Llc | Therapeutic retrieval of targets in biological fluids |
US11285494B2 (en) | 2009-08-25 | 2022-03-29 | Nanoshell Company, Llc | Method and apparatus for continuous removal of sub-micron sized particles in a closed loop liquid flow system |
CA2770695A1 (en) * | 2009-08-25 | 2011-03-03 | Hiroshi Mizukami | Synthesis of oxygen carrying, turbulence resistant, high density submicron particulates |
US10099227B2 (en) | 2009-08-25 | 2018-10-16 | Nanoshell Company, Llc | Method and apparatus for continuous removal of sub-micron sized particles in a closed loop liquid flow system |
WO2011140193A1 (en) * | 2010-05-04 | 2011-11-10 | Massachusetts Institute Of Technology | Implantable dissolved oxygen sensor and methods of use |
US8513309B2 (en) | 2010-10-01 | 2013-08-20 | Oxygen Biotherapeutics, Inc. | Perfluorocarbons for use in treating pruritus |
CN105854034B (en) * | 2016-06-23 | 2018-08-24 | 吉林大学 | The poly- amino-pyrroles composite nanoparticle diagnosis and treatment reagent of metal ion Copper-cladding Aluminum Bar, preparation method and applications |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5498421A (en) * | 1993-02-22 | 1996-03-12 | Vivorx Pharmaceuticals, Inc. | Composition useful for in vivo delivery of biologics and methods employing same |
-
2005
- 2005-03-25 WO PCT/US2005/010112 patent/WO2005097208A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5498421A (en) * | 1993-02-22 | 1996-03-12 | Vivorx Pharmaceuticals, Inc. | Composition useful for in vivo delivery of biologics and methods employing same |
Also Published As
Publication number | Publication date |
---|---|
WO2005097208A2 (en) | 2005-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005097208A3 (en) | Tissue oxygenation measurements | |
Laven et al. | Renal tolerance to prolonged warm ischemia time in a laparoscopic versus open surgery porcine model | |
EP1743591A3 (en) | Apparatus for surgical navigation | |
WO2008053360A3 (en) | Albumin binding molecules and uses thereof | |
WO2012125584A3 (en) | Devices and methods for supporting a patient's legs | |
IL180896A0 (en) | Method of tumour imaging | |
EP1523951A3 (en) | Method and apparatus for surgical navigation | |
WO2005079391A3 (en) | Contrast agents for myocardial perfusion imaging | |
WO2007106142A3 (en) | Process for using optical agents | |
WO2002054946A3 (en) | Ultrasonic imaging of perfusion using gases with different partial pressures | |
WO2005105159A3 (en) | Contrast agents for myocardial perfusion imaging | |
MXPA05007067A (en) | Analyte measuring system which prevents the reuse of a test strip. | |
TW200720648A (en) | Oxidation-resistant indicator macromolecule | |
PL2184977T3 (en) | Use of a globin, a globin protomer or an extracellular hemoglobin for the preservation of organs, tissues, organ and tissue cells | |
WO2006122327A3 (en) | Milk fat globule epidermal growth factor-factor viii and sepsis | |
BRPI0814339A2 (en) | pharmaceutical composition, kit for the preparation of the pharmaceutical composition, conjugate and methods for in vivo optical imaging of the mammalian body, and for the detection, stabilization, diagnosis, monitoring of disease progress or monitoring of the treatment of a disease state. mammal body | |
WO2006072948A3 (en) | Gastro-retentive diagnostic assemblies | |
ATE383854T1 (en) | COMBINATION OF SELECTED OPIOIDS WITH MUSCARINE ANTAGONISTS FOR THE THERAPY OF URINARY INCONTINENCE | |
WO2009091556A3 (en) | Diagnostic methods and kits using fibroblast growth factor-23 | |
ES2521674T3 (en) | Methods of treatment of hyperuricemia and associated pathological conditions | |
WO2006097933A3 (en) | Method for monitoring changes in blood glucose level | |
Shalabi et al. | Impact of pneumoperitoneum on the post-operative renal function and level of acute kidney injury markers: comparison between laparoscopic and open nephrectomy | |
WO2007022484A3 (en) | Acoustically induced blood stasis and in vivo optical spectroscopy | |
EP1780215A4 (en) | Crohn's disease antibody epitope peptide and reagent for testing crohn's disease | |
WO2010066843A3 (en) | Biomolecule complexes as contrast agents in positron emission tomography (pet) based methods for the assessment of organ function |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase |